Skip to main content

Closed

VTVT: vTv Therapeutics Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin-8.3%

ROIC-3.3%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage-507.0×

Current ratio14.36×

Valuation

Unrated

P/E ratio1617.5×

vTv Therapeutics Inc.

VTVTNASDAQ Capital Market·USD·Closed

vTv Therapeutics Inc.

VTVTNASDAQ·USD·Closed

$32.35

−1.01%

$32.35

−$0.33 (1.01%)

52W Range

61thpctl

Volume

2.21×avg

Mkt Cap

84.67MUSD

P/E

1617.5TTM

Div Yield

–ann

52W Range

61thpctl

Volume

2.21×avg

Market Cap

84.67MUSD

P/E Ratio

1617.5TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings